How long is it usually recommended to take bedaquiline to have obvious effects?

Bedaquiline (trade name: Sirturo) is a new anti-tuberculosis drug specially used to treat refractory pulmonary tuberculosis cases such as multi-drug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB). It is the first drug with a new mechanism to be approved for anti-tuberculosis in 40 years. Its main mechanism of action is to inhibit the ATP synthase of Mycobacterium tuberculosis, thereby blocking its energy supply and ultimately killing the bacteria. Although bedaquiline has strong efficacy, its onset of action is slightly slower than that of traditional antibiotics. Patients usually need to take the drug continuously for a period of time before they can observe obvious effects.

In clinical practice, the standard treatment cycle of bedaquiline is 24 weeks (6 months), which is divided into two stages: initial

Bedaquiline is not recommended to be used alone and must be used in combination with other effective anti-tuberculosis drugs to avoid the occurrence of drug resistance. Combination treatment can enhance the efficacy and speed up the killing of bacteria. Multiple studies have shown that adding bedaquiline to the optimized background regimen (optimized background regimen, OBR) can significantly improve the success rate of treatment and reduce the mortality rate. Because of its relatively slow action, the overall effect of combination therapy is usually not apparent until the middle or later stages of the treatment course.

It should be noted that bedaquiline has a certain risk of cardiotoxicity, especially prolongation of the QT interval. Therefore, patients should undergo regular electrocardiogram examinations during the medication period, monitor QTc changes, and avoid co-administration with other drugs that also have the risk of QT prolongation. In addition, if patients experience side effects such as nausea, joint pain, dizziness, abnormal liver function, etc. during treatment, they should report to the doctor in time, and dose adjustments or symptomatic treatment may be performed if necessary to ensure the continuity and safety of treatment. Adhering to a sufficient course of treatment and rational combination of medications are the keys to ensuring the significant therapeutic effect of bedaquiline.

Reference materials:https://www.drugs.com/